期刊文献+

肺癌患者化疗所致恶心呕吐预防流程的构建与实践 被引量:8

Development and practice of chemotherapy-induced nausea and vomiting prevention process management among lung cancer patients
下载PDF
导出
摘要 目的探索肺癌患者化疗所致恶心呕吐预防流程的效果。方法将80例肺癌顺铂化疗患者根据入院时间分组,将2016年3-9月收治的40例患者作为对照组,2016年10月-2017年4月收治的40例患者作为观察组。对照组给予常规肿瘤化疗护理及健康教育,观察组实施化疗所致恶心呕吐预防流程管理。比较两组患者恶心、呕吐发生率及生活质量。结果观察组恶心、呕吐发生率明显低于对照组(P<0.05),而生活质量高于对照组(P<0.05)。结论化疗所致恶心呕吐预防流程管理能有效降低肺癌化疗患者恶心、呕吐发生率,提高患者的生活质量。 Objective To study the effect of chemotherapy induced nausea and vomiting (CINV) prevention process management among lung cancer patients. Methods Totally 80 lung cancer patients underwent cisplatin chem otherapy were divided according to chronological order, 40 patients admitted from March to September 2016 were treated as the control group, and 40 patients admitted from October 2016 to April 2017 were served as the interven tion group. The control group received regular nursing care and health guidance, while the intervention group was given the CINV prevention process management. The incidence of nausea, vomiting and the quality of life score be tween the two groups were compared. Results The incidence of nausea and vomiting of the intervention group was significantly lower than that of the control group(P〈0.05), while the quality of life score was higher than that of the control group(P〈0.05). Conclusion The CINV prevention process management could effectively reduce the inci dence of nausea and vomiting, and improve their quality of life.
作者 陈思涓 谌永毅 谭慧 胡姗 莫海燕 王思琳 Chen Sijuan;Chen Yongyi;Tan Hui;Hu Shan;Mo Haiyan;Wang Silin(School of Nursing,University of South China,Hengyang Hunan 421000;Hunan Cancer Hospital,Changsha Hunan 410013)
出处 《护士进修杂志》 2018年第20期1827-1830,共4页 Journal of Nurses Training
基金 国家癌症中心课题(编号:NCC2017A22) 湖南省研究生科研创新项目(编号:CX2017B565) 湖南省卫生计生委科研课题项目(编号:B20180258)
关键词 肺癌患者 化疗副作用 化疗所致恶心呕吐 流程管理 生活质量 PregnanLung cancer patients Chemotherapy side effects Chemotherapy induced nausea andvomiting Process management Quality of life
  • 相关文献

参考文献7

二级参考文献58

  • 1杨新杰,张树才.雷莫司琼预防肺癌顺铂化疗所致恶心呕吐效果的随机对照临床研究[J].中国肺癌杂志,2005,8(4):322-325. 被引量:13
  • 2易琼,李虹,刁永书.首次化疗患者健康教育需求调查分析[J].护理学杂志(综合版),2005,20(10):55-56. 被引量:23
  • 3陈映霞,秦叔逵,程颖,陈振东,李进,张清媛,潘良熹.盐酸帕洛诺司琼预防化疗性恶心呕吐的多中心双盲随机对照临床研究[J].临床肿瘤学杂志,2007,12(3):161-165. 被引量:48
  • 4NCCN Clinical Practice Guidelines in Oncology: Antiemesis. version 1. 2014[EB/OL] .[2014-02-25]. http://www. nccn. orgl professionalsl physician_glsl pdfl antiemesis. pdf.
  • 5MASCC/ESMO. Antiemetic Guidelines 2013[EB/OL].[2014- 02-25]. http://www. mascc. orgl antiemetic-guidelines; 2013 MASccTM?.
  • 6Gralla RJ, Osoba D, Krismg, et al. Recommendations for the use of anti emetics : evidence-based, clinical practice guidelines[J] .J Clin Oncol, 1999, 17(9): 2971-2994.
  • 7徐建国.手术后恶心呕吐(PONV)防治快捷指南[EB/OL].2012[2014—02-25].http://www.csao].cn/bencandy.php?aid=6246.
  • 8Apfel CC, Heidrich FM,Jukar-Rao S, et al. Evidence-based analysis of risk factors for postoperative nausea and vomiting[J] . BrJ Anaesth, 2012, 109(5): 742-753.
  • 9Warr DG, Grunberg SM, Gralla RJ, et al. The oral NK 1 antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting- Pooled data from 2 randomised, double-blind, placebo controlled trials[J]. EurJ Cancer, 2005, 41(9): 1278-1285.
  • 10Gralla R, Lichinitser M, Van Der Vegt S, et al. Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron[J]. Ann Oncol, 2003, 14 ( 10) : 1570-1577.

共引文献641

同被引文献91

引证文献8

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部